Patient Advocacy
Oncology
Global
Launching the 'SCLC: Nothing Small About It' Campaign

Timeline
12 Weeks
Service Area
Events
Region
Global
This oncology campaign, developed in partnership with Jazz Pharmaceuticals and leading lung cancer associations, was designed to address the unique needs of patients living with small cell lung cancer (SCLC), an often-overlooked disease making up about 13% of US lung cancer diagnoses.
Results
13%
Cancer diagnoses are SCLC
4
Leading lung cancer associations
18
Advocacy thought leaders
The Challenge
Patients and families diagnosed with SCLC often struggle to find relevant resources and support, as most available information centers on the more commonly diagnosed non-small cell lung cancer. The core challenge was to identify unmet psychosocial needs and elevate SCLC as a vital, recognized part of the broader lung cancer community.
Our Approach
We defined the overall program concept and established a "Nothing Small About It" Advisory Board by bringing together tier 1 advocates and survivors. The core activation was developing an unbranded, patient-facing microsite (NothingSmallAboutIt.com) to serve as a centralized resource hub. We conducted video interviews with patients and caregivers to capture compelling stories, developed educational content, and initiated a grassroots social media campaign to drive traffic and connect site visitors to community resources.
The Outcome
The campaign successfully mobilized 18 advocacy thought leaders, including patients and caregivers, who provided valuable insights and shared their stories. The initiative successfully launched a high-quality microsite that seamlessly linked visitors to advocacy partners' resources. Ultimately, the campaign drove increased website and social media engagement and successfully increased the client's recognition as a dedicated industry partner in the lung cancer community.
13% of all U.S. lung cancer diagnoses each year are small cell lung cancer (SCLC), underscoring the specific patient population the initiative aimed to support.
4 leading lung cancer associations teamed up with Jazz Pharmaceuticals to launch this new educational initiative.
18 advocacy thought leaders—including patients and caregivers—were mobilized to provide insights, share their personal stories, and help build the campaign.



